Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (6473V)
April 19 2016 - 5:58AM
UK Regulatory
TIDMAMS
RNS Number : 6473V
Advanced Medical Solutions Grp PLC
19 April 2016
19 April 2016
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Directors' Shareholdings
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and wound care markets, announces that the Board,
following a recommendation from the Remuneration Committee, has
granted new share options to the following Directors under the
Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on
18 April 2016. The vesting period of these options is subject to
certain performance criteria over a three year period.
Director Options prior Options granted Resultant
to grant holding
================== ============== ================ ==========
Chris Meredith
Chief Executive
Officer 938,439 143,553 1,081,992
================== ============== ================ ==========
Mary Tavener
Chief Financial
Officer 568,155 111,050 679,205
================== ============== ================ ==========
Advanced Medical Solutions Group plc also announces that on 18
April 2016, the Board, following a recommendation from the
Remuneration Committee, granted new share options to the following
Directors under the Advanced Medical Solutions Deferred Annual
Bonus Plan (the '2014 DAB').
This award is in respect of the part of their bonus that the
Directors are compulsorily required to defer for the 2015 financial
year. These options vest at the end of three years.
Director Options prior Options granted Resultant
to grant holding
================== ============== ================ ==========
Chris Meredith
Chief Executive
Officer 49,580 32,638 82,218
================== ============== ================ ==========
Mary Tavener
Chief Financial
Officer 36,538 21,332 57,870
================== ============== ================ ==========
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Gary Clarence / Daniel Adams
/ Patrick Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 510 employees. For more
information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDSRUBBGLC
(END) Dow Jones Newswires
April 19, 2016 05:58 ET (09:58 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024